EURAP. The European Registry of Antiepileptic Drugs and Pregnancy;EURAP. Das Europäische Register für Schwangerschaften unter Antiepileptika

Nervenarzt

Volumn 77, Issue 6, 2006, Pages 722-728

  Kretz, R ^a   Coban, I ^a   Gaus, V ^a   Schmitz, B ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Antiepileptic drugs; European Registry of Antiepileptic Drugs and Pregnancy; Pregnancy registry; Teratogenicity

Indexed keywords

ANTICONVULSIVE AGENT;

ARTICLE; DRUG SAFETY; EPILEPSY; EUROPE; FEMALE; GERMANY; GESTATION PERIOD; HEALTH CARE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; PREGNANCY; RISK FACTOR; SAMPLE SIZE; TERATOGENICITY;

ABNORMALITIES, DRUG-INDUCED; ANTICONVULSANTS; EUROPE; FEMALE; HUMANS; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY COMPLICATIONS; PREVALENCE; REGISTRIES; RISK ASSESSMENT; RISK FACTORS;

EID: 33746384076     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-006-2082-2     Document Type: Article

References (30)

1. Adab N, Jacoby A, Smith D et al. (2001) Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 70:15-21
2. Adab N, Kini U, Vinten J et al. (2004) The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 75:1575-1583
3. Alsdorf R, Wyszynski DF (2005) Teratogenicity of sodium valproate. Expert Opin Drug Saf 4:345-353
4. Artama M, Auvinen A, Raudaskoski T et al. (2005) Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology 64:1874-1878
5. Cunnington M, Tennis P, the International Lamotrigine Pregnancy Registry Scientific Advisory Committee (2005) Lamotrigine and the risk of malformations during pregnancy. Neurology 64:955-960
6. DiLiberti JH, Farndon PA, Dennis NR et al. (1984) The fetal valproate syndrome. Am J Med Genet 19:473-481
7. Eriksson K, Viinikainen K, Monkkonen A et al. (2005) Children exposed to valproate in utero-population based evaluation of risks and confounding factors for long-term neurocognitive development. Epilepsy Res 65:189-200
8. Gaily E, Kantola-Sorsa E, Hiilesmaa V et al. (2004) Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 62:28-32
9. Hanson JW, Smith DW (1975) The fetal hydantoin syndrome. J Pediatr 87:285-290
10. Hiilesmaa VK (1992) Pregnancy and birth in women with epilepsy. Neurology 42(Suppl 5):8-11
11. Holmes LB, Wyszynski DF (2004) North American antiepileptic drug pregnancy registry. Epilepsia 45:1465
12. Holmes LB, Wyszynski DF, Lieberman E et al. (2004) The AED (Antiepileptic Drug) pregnancy registry. A 6-year experience. Arch Neurol 61:673-678
13. Kallen B (1994) Maternal carbamazepine and infant spina bifida. Reprod Toxicol 8:203-205
14. Kaneko S, Battino D, Andermann E et al. (1999) Congenital malformations due to antiepileptic drugs. Epilepsy Res 33:145-158
15. Kersting M, Dulon M (2002) Assessment of breastfeeding promotion in hospitals and follow-up survey of mother-infant pairs in Germany: the SuSe Study. Public Health Nutr 5:547-552
16. Lindhout D, Schmidt D (1986) In-utero exposure to valproate and neural tube defects. Lancet 1:1392-1393
17. Lindhout D, Omtzigt JG, Cornel MC (1992) Spectrum of neural tube defects in 34 infants prenatally exposed to antiepileptic drugs. Neurology 42(Suppl 5):111-118
18. Lindhout D, Omtzigt JG (1994) Teratogenic effects of antiepileptic drugs: implications for the management of epilepsy in women of childbearing age. Epilepsia 35(Suppl 4):S19-S28
19. Little BB, Santos-Ramos R, Newell JF et al. (1993) Megadose carbamazepine during the period of neural tube closure. Obstet Gynecol 82(4 pt 2 Suppl):705-708
20. Morrow J, Russell A, Guthrie E et al. (2005) Malformation risks of anti-epileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 77:193-198
21. Nelson K, Holmes LB (1989) Malformations due to presumed spontaneous mutations in newborn infants. N Engl J Med 320:19-23
22. Robert E, Guibaud P (1982) Maternal valproic acid and congenital neural tube defects. Lancet 2:937
23. Rosa F (1991) Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med 324:674-677
24. Russell AJC, Craig JJ, Morrison P et al. (2004) U.K. epilepsy and pregnancy group. Epilepsia 45:1467
25. Samren EB, van Duijn CM, Christiaens GC et al. (1999) Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol 46:739-746
26. Vinten J, Adab N, Kini U et al. (2005) Neuropsychological effects of exposure to anticonvulsant medication in utero. Neurology 64:949-954
27. Vajda F, Lander C, O'Brien T et al. (2004) Australian pregnancy registry of women taking antiepileptic drugs. Epilepsia 45:1466
28. Vajda FJ, Eadie MJ (2005) Maternal valproate dosage and foetal malformations. Acta Neurol Scand 112:137-143
29. Waters CH, Belai Y, Gott PS et al. (1994) Outcomes of pregnancy associated with antiepileptic drugs. Arch Neurol 51:250-253
30. Wyszynski DF, Nambisan M, Surve T et al. (2005) Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology 64:961-965